Abstract：
The year of 1992 is very important milestone in history of Russian pharmaceutical market. It began not in January 1922, but in December 1991, when the President and Government enactments to open free market for medications were promulgated. The advisers of B. N. Yeltsin considered market economy as reliable mean to overcome medicinal deficiencies, corruption and bureaucratic monopoly. However, panacea did not work. Moreover, it caused completely new problems. The human and state security implies protection from threats of dependencies. The unprepared dive into market plunged Russians and the country into severe dependence on import of medications and foreign pharmaceutical companies. The proposed study expands our publications in this journal and in journal \"Pharmacy\" in 2022. At that time, analysis of medication scarcity was implemented on the basis of published sources and relied on journalistic evidences. The current study is carried out on the basis of archival documents of the Ministry of Health Care of the Russian Federation and authors interviews of representatives of regulator. The second report reconstructs the sequence of the emergence and correlation of the structural elements of the Russian pharmaceutical market.
摘要：
1992年是俄罗斯医药市场历史上非常重要的里程碑。它不是始于1922年1月，而是始于1991年12月，当时总统和政府颁布了开放药品自由市场的法令。B.N.叶利钦的顾问认为市场经济是克服药物缺陷的可靠手段，腐败和官僚垄断。然而,万灵药不起作用。此外，它引起了全新的问题。人类和国家安全意味着保护免受依赖的威胁。毫无准备的进入市场使俄罗斯人和该国严重依赖药品和外国制药公司的进口。这项拟议的研究扩大了我们在本杂志和2022年“药学”杂志上的出版物。当时,对药物稀缺性的分析是根据已发布的来源进行的，并依赖于新闻证据。本研究是根据俄罗斯联邦卫生部的档案文件和作者对监管机构代表的采访进行的。第二份报告重建了俄罗斯医药市场结构要素的出现和相关性的顺序。
